Kansas Center for Metabolism and Obesity REsearch (KC-MORE) - Metabolism Core
堪萨斯代谢与肥胖研究中心 (KC-MORE) - 代谢核心
基本信息
- 批准号:10598029
- 负责人:
- 金额:$ 29.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
METABOLISM CORE: PROJECT SUMMARY
Metabolism plays a fundamental role in the development of obesity and the pathological consequences of obesity
that lead to chronic disease. Dysregulation of energy balance and impaired storage or oxidation of substrates
are fundamental features of developing obesity and metabolic disease. Metabolic dysregulation is driven by both
alterations in cellular mitochondrial function and disruptions in whole body metabolic homeostasis. Therefore,
metabolic research that connects cellular mitochondrial energetics to whole body in vivo substrate metabolism
and energy expenditure is critical for understanding mechanisms underlying metabolic dysfunction, obesity, and
obesity-related disease states. The Metabolism (MET) core will provide the Kansas Center for Metabolism and
Obesity REsearch (KC-MORE) with expertise, methodologies, and equipment for the study of “metabolism” from
the cell to the whole body. Core missions of the MET core will be to develop a new central MET core facility for
pre-clinical Models (rodents) that provides a host of key measurements, allowing for thorough metabolic
phenotyping. These approaches will include expertise and equipment to quantify real time measures of in-vivo
energy metabolism, substrate metabolism, food intake regulation, and glucose/insulin tolerance testing along
with non-invasive measures of body composition in pre-clinical rodent models (rat and mice). A second core
feature of the MET core will be to provide resources to investigators to quantify mitochondrial energetics in cells
and tissues from both rodent and human samples. Finally, the MET core will also have the capability to perform
metabolic isotope methodologies (isotopic labeled glucose, fatty acids, etc.) for use in humans or rodent models
(in-vivo or ex-vivo) to quantify overall metabolic flux. In summary, the MET core services will be organized to
provide state-of-the art core services to investigators studying metabolism in pre-clinical rodent model systems
and to translational measures of mitochondrial energetics and stable metabolic isotopes for use in cells, tissues,
rodents, and human participants. The MET core is also designed to largely parallel the capabilities of the Human
Energy Balance core so that scientists in the KC-MORE can conduct translational studies in both rodents and
humans.
代谢核心:项目摘要
代谢在肥胖的发展和肥胖的病理后果中起着基本作用
导致慢性疾病。能量平衡失调和底物存储或氧化受损或氧化
是发展肥胖和代谢疾病的基本特征。代谢失调均由两者驱动
细胞线粒体功能的改变和全身代谢稳态的破坏。所以,
将细胞线粒体能量与整个身体连接到体内底物代谢的代谢研究
能量支出对于理解代谢功能障碍,肥胖和
肥胖相关疾病状态。新陈代谢(MET)核心将为堪萨斯州的新陈代谢中心和
肥胖研究(KC-more)具有专业知识,方法和设备,用于研究“代谢”
整个身体的细胞。大都会核心的核心任务将是开发一个新的中央大都会核心设施
临床前模型(啮齿动物)提供了许多关键测量,可以彻底代谢
表型。这些方法将包括量化体内实时度量的专业知识和设备
能源代谢,底物代谢,食物摄入调节和葡萄糖/胰岛素耐受性测试
在临床前啮齿动物模型(大鼠和小鼠)中的身体组成无创测量。第二个核心
MET核心的特征是向研究人员提供资源以量化细胞中的线粒体能量
以及来自啮齿动物和人类样品的组织。最后,MET核心也将具有执行的能力
代谢同位素方法(同位素标记的葡萄糖,脂肪酸等)用于人类或啮齿动物模型
(体内或前体)来量化总体代谢通量。总而言之,MET核心服务将组织到
向研究前临床前啮齿动物模型系统中研究代谢的研究人员提供最先进的核心服务
并翻译了线粒体能量和稳定的代谢同位素的测量,用于细胞,组织,
啮齿动物和人类参与者。 MET核心还旨在在很大程度上与人类的能力相似
能量平衡核心使KC-More中的科学家可以在啮齿动物和
人类。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Paige C Geiger的其他基金
Feasibility of Improving Glycemia to Prevent Alzheimer's Disease
改善血糖预防阿尔茨海默病的可行性
- 批准号:1063368810633688
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
PROTECTIVE ROLE OF HEAT SHOCK PROTEINS IN INSULIN RESISTANCE
热休克蛋白在胰岛素抵抗中的保护作用
- 批准号:83597448359744
- 财政年份:2011
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Targeting stress-mediated pathways in the treatment of muscle insulin resistance
靶向应激介导的途径治疗肌肉胰岛素抵抗
- 批准号:81213838121383
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Targeting stress-mediated pathways in the treatment of muscle insulin resistance
靶向应激介导的途径治疗肌肉胰岛素抵抗
- 批准号:86637798663779
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Targeting stress-mediated pathways in the treatment of muscle insulin resistance
靶向应激介导的途径治疗肌肉胰岛素抵抗
- 批准号:84693728469372
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
PROTECTIVE ROLE OF HEAT SHOCK PROTEINS IN INSULIN RESISTANCE
热休克蛋白在胰岛素抵抗中的保护作用
- 批准号:81675248167524
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Targeting stress-mediated pathways in the treatment of muscle insulin resistance
靶向应激介导的途径治疗肌肉胰岛素抵抗
- 批准号:82785658278565
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Targeting stress-mediated pathways in the treatment of muscle insulin resistance
靶向应激介导的途径治疗肌肉胰岛素抵抗
- 批准号:79850657985065
- 财政年份:2010
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
相似国自然基金
脂肪组织新型内分泌因子的鉴定及功能研究
- 批准号:82330023
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管周围脂肪组织TRPV1通道通过脂联素调控肥胖相关高血压的机制研究
- 批准号:82300500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:1075128410751284
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Controlling Adipocyte-Myofibroblast Interactions to Improve Healing
控制脂肪细胞-肌成纤维细胞相互作用以改善愈合
- 批准号:1058285810582858
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Investigating a role for eNAMPT-containing extracellular vesicles in mitigating age- and Alzheimer Disease-related cognitive decline
研究含有 eNAMPT 的细胞外囊泡在缓解年龄和阿尔茨海默病相关认知衰退中的作用
- 批准号:1060737610607376
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
Physiological changes underlying the weight loss plateau in humans
人类减肥平台期的生理变化
- 批准号:1073432310734323
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别:
MicroRNA 374 as an Epigenetic Regulator of Chronic Pain
MicroRNA 374 作为慢性疼痛的表观遗传调节剂
- 批准号:1074723710747237
- 财政年份:2023
- 资助金额:$ 29.71万$ 29.71万
- 项目类别: